- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pure Red-Cell Aplasia
Total 3902 results
-
Hospital General de MexicoRecruiting
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Lymphoma | Multiple Myeloma | Hematopoietic and Lymphoid System Neoplasm | Chronic LeukemiaUnited States
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
University of Illinois at ChicagoRecruitingMultiple MyelomaUnited States
-
Cartesian TherapeuticsRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States, Turkey
-
M.D. Anderson Cancer CenterRecruiting
-
Omar Nadeem, MDTakedaRecruitingMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
American Society of Clinical OncologyBristol-Myers Squibb; Eli Lilly and Company; Bayer; Merck Sharp & Dohme LLC; Pfizer; AstraZene... and other collaboratorsRecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
Centre Hospitalier Henri Duffaut - AvignonInstitut de Formation en Ostéopathie du Grand AvignonTerminatedMultiple Myeloma | Colorectal Cancer | Lung Cancer | Non Hodgkin LymphomaFrance
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Bristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Wake Forest University Health SciencesAtrium Health Levine Cancer InstituteTerminatedChemotherapy-induced Peripheral NeuropathyUnited States
-
Fred Hutchinson Cancer CenterUniversity of Washington; Seattle Children's HospitalActive, not recruitingLymphoma | Leukemia | Multiple Myeloma | Myelodysplastic Syndrome | ImmunodeficiencyUnited States
-
Nantes University HospitalWithdrawn
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMultiple Myeloma | AL AmyloidosisUnited States
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Duke UniversityCompletedHematopoietic Neoplasms (Leukemia, Lymphoma, Multiple Myeloma)United States
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la LoireCompletedMultiple Myeloma | Renal FailureFrance, Belgium, Algeria, Lebanon
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
CelgeneCompletedMultiple MyelomaAustria, Italy, France, Spain, Netherlands, Germany, Greece, United Kingdom
-
Massachusetts General HospitalEmory University; University of Rochester; Amgen; University Hospitals Cleveland...UnknownMultiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRenal Insufficiency | Multiple MyelomaUnited Kingdom, Spain, United States
-
University Hospital, Clermont-FerrandCompletedMultiple Myeloma | Chemotherapy Induced Peripheral NeuropathyFrance
-
Assistance Publique - Hôpitaux de ParisUnknownMultiple Myeloma | Vertebral FractureFrance
-
Medical College of WisconsinWithdrawnRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States, Italy
-
Immunovative Therapies, Ltd.Hadassah Medical OrganizationCompletedLymphoma | Leukemia | Multiple Myeloma | Hematological MalignancyIsrael
-
University of Maryland, BaltimoreCompletedMultiple Myeloma | Peripheral NeuropathiesUnited States
-
Beth FaimanNational Cancer Institute (NCI)TerminatedGlutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving BortezomibMultiple Myeloma | Peripheral Neuropathy | Chemotherapeutic Agent ToxicityUnited States
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
University Health Network, TorontoCompletedMultiple Myeloma | Renal FailureCanada
-
Masonic Cancer Center, University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited States
-
New Mexico Cancer Care AllianceNovartisTerminatedMultiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Genzyme, a Sanofi CompanyNo longer availableMultiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease
-
NYU Langone HealthUnicorn Pacific CorporationTerminatedMyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMultiple Myeloma | MucositisUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple MyelomaUnited States